Age 18 or older.
Patients diagnosed with acromegaly with GH-secreting pituitary adenoma on sellar MRI, meeting the biochemical criteria outlined above (refer to 1. Diagnosis of acromegaly) and with typical acromegalic features.
No prior use of somatostatin analogues.
Adequate hepatic and renal function
Provision of a signed written informed consent

NCT02427295_inc_T1
Person
Age
NCT02427295_inc_T2
Value
18 or older
NCT02427295_inc_T3
Condition
acromegaly
NCT02427295_inc_T4
Condition
GH-secreting pituitary adenoma
NCT02427295_inc_T5
Procedure
sellar MRI
NCT02427295_inc_T6
Qualifier
biochemical criteria outlined above
NCT02427295_inc_T7
Condition
acromegalic features
NCT02427295_inc_T8
Qualifier
typical
NCT02427295_inc_T9
Drug
somatostatin analogues
NCT02427295_inc_T10
Negation
No
NCT02427295_inc_T11
Temporal
prior
NCT02427295_inc_T12
Condition
quate he al function
Pr
NCT02427295_inc_T13
Condition
quate hepatic an ction
Pr